| ||||||||||||||
|
|
|||||||||||||
Anesthesia & Analgesia, Vol 83, 117-122, Copyright © 1996 by International Anesthesia Research Society
GENERAL ARTICLES |
FJ Pueyo, F Carrascosa, L Lopez, MJ Iribarren, F Garcia-Pedrajas and A Saez
Department of Anesthesiology and Critical Care, University Clinic, School of Medicine, University of Navarra, Pamplona, Spain.
The aim of this study was to compare the efficacy and safety of ondansetron plus droperidol with each drug alone or placebo in the prevention of postoperative nausea and vomiting (PONV). One hundred females, aged 18-65 yr, ASA physical status I-II, undergoing general anesthesia for elective abdominal surgery were included in a prospective, double-blind, placebo-controlled, randomized study. A standardized anesthetic technique and postoperative analgesia (ketorolac plus patient-controlled analgesia [PCA] with morphine) were used in all patients. Patients were randomly assigned to receive placebo (Group 1, n = 25), droperidol 2.5 mg with induction of anesthesia and 1.25 mg 12 h later (Group 2, n = 25), ondansetron 4 mg with induction (Group 3, n = 25), and ondansetron plus droperidol at the same doses as Groups 3 and 2, respectively (Group 4, n = 25). A complete response, defined as no PONV in 48 h, occurred in 28% of patients in Group 1, 60% in Group 2 (P < 0.05 vs Group 1), 56% in Group 3 (P < 0.05 vs Group 1), and 92% in Group 4 (P < 0.01 vs Groups 1, 2, and 3). Sedation was significantly greater with droperidol (Groups 2 and 4) for 12 h postoperatively. In conclusion, the combination of ondansetron plus droperidol was more effective than each antiemetic alone or placebo in the prevention of PONV in women undergoing elective abdominal surgery.
This article has been cited by other articles:
![]() |
L. Grecu, E. A. Bittner, J. Kher, S. E. Smith, and C. E. Rosow Haloperidol Plus Ondansetron Versus Ondansetron Alone for Prophylaxis of Postoperative Nausea and Vomiting Anesth. Analg., May 1, 2008; 106(5): 1410 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. V. Chan, K. C. Choi, T. Gin, P. T. Chui, T. G. Short, P. M. Yuen, A. H. Y. Poon, C. C. Apfel, and T. J. Gan The Additive Interactions Between Ondansetron and Droperidol for Preventing Postoperative Nausea and Vomiting Anesth. Analg., November 1, 2006; 103(5): 1155 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Habib, H. E. El-Moalem, and T. J. Gan The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials: [L'efficacite de la combinaison des antagonistes des recepteurs 5-HT3 et du droperidol ou de la dexame- thasone est similaire pour prevenir les NVPO. Une meta-analyse d'essais randomises et controles] Can J Anesth, April 1, 2004; 51(4): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gan Postoperative Nausea and Vomiting--Can It Be Eliminated? JAMA, March 13, 2002; 287(10): 1233 - 1236. [Full Text] [PDF] |
||||
![]() |
C. J. Ryan, N. Tabet, R. Howard, D. Meagher, J Haines, P Barclay, and T Wauchob Optimising management of delirium BMJ, June 30, 2001; 322(7302): 1602 - 1602. [Full Text] |
||||
![]() |
P. E. Scuderi, R. L. James, L. Harris, and G. R. Mims III Multimodal Antiemetic Management Prevents Early Postoperative Vomiting After Outpatient Laparoscopy Anesth. Analg., December 1, 2000; 91(6): 1408 - 1414. [Abstract] [Full Text] [PDF] |
||||
![]() |
Editorial: Postoperative nausea and vomiting--time for balanced antiemesis? Br. J. Anaesth., November 1, 2000; 85(5): 675 - 677. [Full Text] [PDF] |
||||
![]() |
A. B. Ahmed, G. J. Hobbs, and J. P. Curran Randomized, placebo-controlled trial of combination antiemetic prophylaxis for day-case gynaecological laparoscopic surgery{dagger} Br. J. Anaesth., November 1, 2000; 85(5): 678 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Loewen, C. A. Marra, and P. J. Zed 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting Can J Anesth, October 1, 2000; 47(10): 1008 - 1018. [Abstract] [PDF] |
||||
![]() |
O. Wu, S. E. Belo, and G. Koutsoukos Additive anti-emetic efficacy of prophylactic ondansetron with droperidol in out-patient gynecological laparoscopy Can J Anesth, June 1, 2000; 47(6): 529 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Henzi, J. Sonderegger, and M. R. Tramer Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting Can J Anesth, June 1, 2000; 47(6): 537 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Domino, E. A. Anderson, N. L. Polissar, and K. L. Posner Comparative Efficacy and Safety of Ondansetron, Droperidol, and Metoclopramide for Preventing Postoperative Nausea and Vomiting: A Meta-Analysis Anesth. Analg., June 1, 1999; 88(6): 1370 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R Tramèr, D J. M Reynolds, R A. Moore, and H. J McQuay When placebo controlled trials are essential and equivalence trials are inadequate BMJ, September 26, 1998; 317(7162): 875 - 880. [Full Text] |
||||
|